Skip to main content
Premium Trial:

Request an Annual Quote

Kinaxo Inks US, Japan Marketing Deals

NEW YORK (GenomeWeb News) – Martinsried, Germany-based Kinaxo Biotechnologies today said that it has inked sales and marketing pacts in the US and Japan for its Cellular Target Profiling service.
In the US, New York-based BioCatalyst International will support the introduction of the service, while UK-based BioFocus DPI will provide similar support in Japan.
Kinaxo’s CTP Service enables drug developers to determine the native cellular protein interactions of small molecule compounds in a physiological setting.
Further terms and details of the partnerships were not disclosed.